Creative Medical Technology started recruitment of clinical sites for StemSpine®, a regenerative stem cell procedure for the treatment of degenerative disc disease.
The company will seek out locations across the U.S., geographically dispersed to provide maximum access to potential patients. Patient recruitment will begin immediately upon signing of the first clinical site.
The company was granted U.S. Patent No. 9,598,673, which covers the use of any mesenchymal stem cells, both autologous or allogeneic, for reduction of lower back pain when injected into the major muscles of the lower back.
Creative Medical Technology started recruitment of clinical sites for StemSpine®, a regenerative stem cell procedure for the treatment of degenerative disc disease.
The company will seek out locations across the U.S., geographically dispersed to provide maximum access to potential patients. Patient recruitment will begin immediately upon...
Creative Medical Technology started recruitment of clinical sites for StemSpine®, a regenerative stem cell procedure for the treatment of degenerative disc disease.
The company will seek out locations across the U.S., geographically dispersed to provide maximum access to potential patients. Patient recruitment will begin immediately upon signing of the first clinical site.
The company was granted U.S. Patent No. 9,598,673, which covers the use of any mesenchymal stem cells, both autologous or allogeneic, for reduction of lower back pain when injected into the major muscles of the lower back.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
